Gensciences
Nantong
About Gensciences
Suns Bio Group offers new drug research and development, production, and sales. They offer innovative drugs, strive for high safety, high effectiveness, and a high success rate simultaneously, become a continuous innovator in the global biopharmaceutical field, and benefit patient groups.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 251 – 500
- Total funding: $123.6M
- Funding stage: Late Stage Venture
- Last round: Series D (Jun 2024)
- Website: gensciences.com
- Phone: 010-678-06990
Industries & Categories
Biotechnology, Clinical Trials, Health Care, Pharmaceutical, Product Research
Social Profiles
Canonical: https://fsome.com/organization/gensciences-7612 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.